Philip Frerichs

Wölbern-PE is an active manager which invests across the buyout, venture capital and mezzanine segments, both directly and indirectly. Their multi-manager strategies cover buy-outs across sectors as well as venture capital investments in specific industries, namely life sciences and clean technology. Buyouts investments use a purely fund-of-fund approach while the sector funds follow a hybrid strategy mixing direct and indirect investments. In terms on buyouts, Wölbern-PE focuses on Western Europe and the US, investing between EUR 5 and 15 million per fund, for a total of EUR 20 to 30 million annually across three to five transactions. They target funds which are EUR 500 million to 2 billion in size, managed by cohesive teams with a successful track record in their chosen field. They may invest in first-time funds except when raised by first-time managers. Direct investments target innovative companies in sectors including biotechnology, pharmacology, medical technology, diagnostics, health care and cleantech (power, water, materials and transport). Wölbern-PE typically exits investments through trade sales and IPOs.